Related Experiment Video
Updated: Nov 8, 2025

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles
Published on: July 26, 2024
[Assessment and intervention strategies for sarcopenia in patients with liver cirrhosis]
1The Third Central Clinical College of Tianjin Medical University, Tianjin 300170, China Department of Nutrition, The Third Central Hospital of Tianjin, Tianjin 300170, China Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Tianjin 300170, China Artificial Cell Engineering Technology Research Center, Tianjin 300170, China Tianjin Institute of Hepatobiliary Disease, Tianjin 300170, China.
Abstract:
Sarcopenia is a common complication in patients with liver cirrhosis, which has an adverse effect on the clinical outcome and prognosis. Attention must be paid to early detection and active diagnosis and treatment. Clinically, the diagnosis process of finding suspicious cases can be traced through screening-assessment-diagnosis-severity evaluation. On the ground of treating liver cirrhosis and its complications, reasonable nutritional intervention and exercise are currently important measures for the treatment of liver cirrhosis with sarcopenia, and the role of hormone supplementation and drug therapy for skeletal muscle metabolism needs to be further investigated.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Cardiomyopathy VI: Nursing Management
Atherosclerosis IV: Nursing Management
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

